Stemmed Implant Technology Inc.

About The Market

Stock Market

Europe currently forms the world's largest market for dental implants with a 42% market share, and is also expected to have the highest annual increase, 7%, from 2010 to 2015.

According to estimates and projections, the US dental implant market will exceed $1 billion in 2013.

The tooth restoration market is highly under-penetrated globally, the market is expected to grow due to the rising dentulous population worldwide.


Dental Implants

Conventional Dental Implant

Dental implants already hold a substantial 18% share of the global dental device market; and are also expected to have one of the highest growth rates amongst all dental device submarkets.

This is primarily because dental implants offer an effective treatment for edentulism and because of the rising demand for cosmetic dentistry worldwide across all age groups.

The aging baby-boomer population in developed nations offers an especially
high-growth opportunity, as this consumer segment is characterized by high disposable income, and also by an increased need for dental care due to longer life expectancy. Tooth loss has been a major problem North America, Europe and others. About 6 to 10 per cent people in these regions are toothless, while about 240 million people have lost one or more teeth.


The global Dental Implant market is being forecasted to grow at 6% from $3.2 billion (US$) in 2010 to $4.2 billion (US$) in 2015. SIT initial product and technology launch will target the dental implant market.

Related Article


The global Orthopaedic Implant market is forecast to grow to over $41 billion (US$) by 2016. Joint reconstruction will remain the largest orthopaedic implants category, which is expected to grow at 7.4% CAGR during 2009–2016 to reach $22.9 billion (US$). SIT secondary product and technology launch will target the joint reconstruction implant market.

Related Article


Global Veterinary Implantology is a relatively new field and the global market is expected to reach $270 million (US$) by 2021. SIT tertiary product launch will target the veterinary implant market.

Related Article